Jia Xin Yu
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Biomedical Engineering
- Pulmonary and Respiratory Medicine
- Co-authors
- Vanessa M. Hubbard-LuceyJun TangJeffrey P. HodgeSamik UpadhayaCristina OlivaYunqing LinJay R. CampbellRevati J. Tatake
- Topics
- CAR-T cell therapy research (5 papers)Cancer Immunotherapy and Biomarkers (3 papers)Cancer Genomics and Diagnostics (3 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesChina
In The Last Decade
Jia Xin Yu
24 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 843
- Immunology 479
- Molecular Biology 361
- Biomedical Engineering 167
- Pulmonary and Respiratory Medicine 166
Countries citing papers authored by Jia Xin Yu
This map shows the geographic impact of Jia Xin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Xin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Xin Yu more than expected).
Fields of papers citing papers by Jia Xin Yu
This network shows the impact of papers produced by Jia Xin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Xin Yu. The network helps show where Jia Xin Yu may publish in the future.
Co-authorship network of co-authors of Jia Xin Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Jia Xin Yu. A scholar is included among the top collaborators of Jia Xin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Xin Yu. Jia Xin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 69 | |
| 2 | 9 | |
| 3 | 11 | |
| 4 | 23 | |
| 5 | 18 | |
| 6 | 13 | |
| 7 | 123 | |
| 8 | 57 | |
| 9 | 74 | |
| 10 | 100 | |
| 11 | 18 | |
| 12 | 17 | |
| 13 | 74 | |
| 14 | 2 | |
| 15 | 196 | |
| 16 | The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitorsbreakdown → | 301 |
| 17 | 8 | |
| 18 | 11 | |
| 19 | [Genetic basis of systemic sclerosis]. | 3 |
| 20 | 1 |
About Jia Xin Yu
Jia Xin Yu is a scholar working on Oncology, Cancer Research and Reproductive Medicine, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (843 citations), Immunology (479 citations) and Cancer Research (128 citations). Jia Xin Yu has collaborated with scholars based in United States and China. Frequent co-authors include Vanessa M. Hubbard-Lucey, Jun Tang, Jeffrey P. Hodge, Samik Upadhaya, Cristina Oliva, Yunqing Lin, Jay R. Campbell, Revati J. Tatake, Benjamin G. Vincent and Lisa A. Carey. Their work appears in journals such as Journal of Clinical Oncology, Nature Reviews Drug Discovery and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.